120 related articles for article (PubMed ID: 10983860)
1. Azithromycin versus pivampicillin in the treatment of acute exacerbations of chronic bronchitis: a single-blind, double-dummy, multicentre study.
Schouenborg P; Gerdes N; Rasmussen H; Wickers-Nielsen N; Mathiassen E
J Int Med Res; 2000; 28(3):101-10. PubMed ID: 10983860
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
3. A comparison of pivmecillinam/pivampicillin and amoxycillin in acute exacerbations of chronic bronchitis.
Atkins MJ; Talbot DJ
J Int Med Res; 1987; 15(2):115-20. PubMed ID: 3556261
[TBL] [Abstract][Full Text] [Related]
4. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group.
Biebuyck XA
J Int Med Res; 1996; 24(5):407-18. PubMed ID: 8895044
[TBL] [Abstract][Full Text] [Related]
5. A clinical comparative study of ofloxacin and pivampicillin in acute exacerbations of chronic bronchitis.
Egede F; Kristensen I
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():139-42. PubMed ID: 3182456
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
O'Doherty B; Daniel R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290
[TBL] [Abstract][Full Text] [Related]
9. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
[TBL] [Abstract][Full Text] [Related]
10. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
Jorgensen DM
Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975
[TBL] [Abstract][Full Text] [Related]
11. Double-blind comparison of pivmecillinam plus pivampicillin ('Miraxid') with pivampicillin alone in chronic bronchitis: a Danish multi-centre study.
Bukh N
Pharmatherapeutica; 1983; 3(6):422-8. PubMed ID: 6312461
[TBL] [Abstract][Full Text] [Related]
12. [Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years].
Eickhoff JH; Frimodt-Møller N; Walter S; Frimodt-Møller C
Ugeskr Laeger; 2000 Feb; 162(7):936-9. PubMed ID: 10740436
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of Miraxid (pivmecillinam plus pivampicillin) and Augmentin (amoxycillin plus clavulanic acid) in the treatment of lower respiratory tract infections in general practice.
McGhie D; Kerfoot P; Talbot DJ
J Int Med Res; 1986; 14(5):254-60. PubMed ID: 3533674
[TBL] [Abstract][Full Text] [Related]
14. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Castaldo RS; Celli BR; Gomez F; LaVallee N; Souhrada J; Hanrahan JP
Clin Ther; 2003 Feb; 25(2):542-57. PubMed ID: 12749513
[TBL] [Abstract][Full Text] [Related]
15. Randomised trial of pivampicillin plus pivmecillinam vs. pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae.
Johansen HK; Børch K; Espersen F; Koch C; Høiby N
Curr Med Res Opin; 1999; 15(4):300-9. PubMed ID: 10640263
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections.
Laurent K
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():115-24. PubMed ID: 8818852
[TBL] [Abstract][Full Text] [Related]
17. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
[TBL] [Abstract][Full Text] [Related]
18. A multicentre general practice study comparing pivampicillin (Pondocillin) and amoxycillin (Amoxil) in respiratory tract infections.
Moran DG
J Int Med Res; 1983; 11(6):370-4. PubMed ID: 6360752
[TBL] [Abstract][Full Text] [Related]
19. [Pivampicillin in exacerbations of chronic bronchitis].
Haanaes OC; Grimne G
Tidsskr Nor Laegeforen; 1980 Nov; 100(32):1900-2. PubMed ID: 7006146
[No Abstract] [Full Text] [Related]
20. Randomized, double-blind, double-dummy study comparing the efficacy and safety of amoxycillin 1 g bd with amoxycillin 500 mg tds in the treatment of acute exacerbations of chronic bronchitis.
Georgopoulos A; Borek M; Ridl W;
J Antimicrob Chemother; 2001 Jan; 47(1):67-76. PubMed ID: 11152433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
